Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
213
Frequently Asked Questions
What is Market Cap of Protalix BioTherapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Protalix BioTherapeutics Inc. market cap is $188.17M.
What is the 52-week high for Protalix BioTherapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Protalix BioTherapeutics Inc. 52 week high is $3.10 as of October 25, 2025.
What is the 52-week low for Protalix BioTherapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Protalix BioTherapeutics Inc. 52 week low is $1.07 as of October 25, 2025.
What is the PE ratio of Protalix BioTherapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Protalix BioTherapeutics Inc.’s P/E ratio is 31.89.
What is the Price-to-Book ratio of Protalix BioTherapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Protalix BioTherapeutics Inc. P/B ratio is 3.7707.
What is the 50-day moving average of Protalix BioTherapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Protalix BioTherapeutics Inc. 50-day moving average is $1.97.
How many employess does Protalix BioTherapeutics Inc. has?
